The Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal Men

NCT00696748 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome
Hypogonadism

Interventions

DRUG: Nebido (testosterone undecanoate)
DRUG: Placebo

Sponsor

Russian Academy of Medical Sciences